Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision Certified by Illumina

NEW YORK (GenomeWeb News) – Genomics services provider DNAVision said today that it has been certified as a collaborative partner to offer Illumina's Infinium Genotyping.

The Belgian firm said that the Illumina CSPro certification is a two-phase process that covers minimum data generation, data certification, and an on-site audit of the facility and company processes.

"We collaborate with our customers during the whole genotyping process, bringing our expertise from study design to thorough data interpretation within the highest quality assurance procedures," DNAVision Business Development Manager Sebastien Massart said in a statement.

DNAVision is Illumina's first partner in Belgium that is CSPro certified for Infinium services.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.